EGFR mutation testing and treatment with tyrosin-kinase inhibitors in patients with metastatic non-small cell lung cancer treated by office based medical oncologists in Germany – data from the clinical registry on lung cancer (TLK). 7. Juni 2015 Bertram, M., Petersen, V., Heßling, J., Tessen, H.W., Münz, M., Jänicke, M., Spring, L., Marschner, N., 2015. Oncol Res Treat 38 (suppl 5)(V886), 269. doi:10.1159/000439070 Abstract Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice. Becker, M., Tschechne, B., Reeb, M., Schwinger, U., Bruch, H.-R., Frank, M., Straßl, L., 2015. Ann Hematol 94, 1553–1558. doi:10.1007/s00277-015-2404-1… Weiterlesen Prophylactic treatment of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with NHL: Subgroup analysis of the non-interventional study NADIR Fietz, T., Wolff, T., Sandner, R., Janssen, J., Hurzt, H.-J., Heits, F., Weide, R., Weißenborn, G., Losem, C., Lück, A., Kurbacher, C., Teichmann, B., Harde,… Weiterlesen